Tag: company

WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197) titled, "Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models."

Transaction in Own Shares

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 18 July 2025 – 6 PM CET

VALLOUREC
French limited liability company (société anonyme) with a Board of Directors
with share capital of € 4,767,162.72
Registered office: 12, rue de la Verrerie – 92190 Meudon, France
Registered on the Nanterre Trade and Companies Register under n° 552 142 200

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter 

The Manufacturing Execution System Companies Quadrant offers an in-depth analysis of the global Manufacturing Execution System (MES) market, highlighting key players, technological advancements, and emerging trends. Over 100 companies were evaluated, with the top 16 recognized as quadrant leaders. MES software is crucial in monitoring production lifecycles, integrating with ERP to boost efficiency. Market growth is fueled by mass production demands, IT and OT integration, and automation advancements. Key segments include offerings, deployment modes, and industry applications. Leading companies like Siemens, Dassault Systèmes, and SAP SE drive innovation through R&D and strategic partnerships, positioning themselves at the forefront of this dynamic market.

The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, innovations, and trends, it identifies the top 25 companies as quadrant leaders among over 100 evaluated. Vascular access devices (VADs), crucial for treatments like chemotherapy and dialysis, are set to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030 at a 7.1% CAGR, fueled by rising demand and investments despite a skilled professional shortage. Key players include Beckton Dickinson, Teleflex, and ICU Medical, known for expanding portfolios through strategic acquisitions and innovations. The quadrant evaluates companies based on revenue, growth strategies, and product footprint across device types and applications.